The level of METTL14 (Zhang et al., 2021a; Liu et al., 2022d) and eukaryotic initiation factor 3 (eIF3A) (Zhang et al., 2021b) in RCC was significantly decreased. This evidence concerns the gene METTL14 and renal cell carcinoma.